Skip to main content
OpenTrials
Completed

NCT Number: NCT06152016

BE FAST vs. FAST: A Study in the General Public.

A randomized, blinded prospective study assessing retention of two stroke mnemonics (BE FAST and FAST) in the general public after receiving brief stroke education. Participants were randomized to one of two education arms and retention was tested at 3 different time intervals.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Stroke Brain Diseases Cardiovascular Diseases Central Nervous System Diseases Cerebrovascular Disorders Nervous System Diseases Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Aurora BayCare Medical Center

Green Bay, Wisconsin, 54311, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Subject 18 years of age or older
  • Subject speaks English (Does not need interpreter)
  • Subject able to read English
  • Subject willing to provide a phone number for future follow up
  • Subject willing and agreeable to up to 2 phone follow up calls
  • Subject willing to provide verbal consent to participate

Exclusion criteria

  • Subject non-English speaking (needs interpreter)
  • Subject has visual or hearing impairment
  • Subject has history of Dementia or a learning disability
  • Subject had stroke education within the past year
  • Subject had a previous stroke

Treatment and study plan

BE-FAST

Other

This intervention includes those randomized to the education with the BE-FAST mnemonic.

FAST

Other

This intervention includes those randomized to the education with the FAST mnemonic.

Primary outcomes

  1. Recall Visit 1

    Time frame: 60 minutes

    Number/percentage of participants in the FAST and BE-FAST groups at Visit 1 who accurately recall the mnemonic they were taught during the education session.

Secondary outcomes

  1. Retention Rate Symptom

    Time frame: 30 days

    Retention rate of each stroke symptom in the mnemonic

  2. Recall Rate Symptom

    Time frame: 30 days

    Total number of stroke symptoms that were accurately recalled by the participants

  3. Recall Participant Percentage

    Time frame: 30 days

    Number/percentage of participants able to recall all the symptoms included in the mnemonic

  4. Patrial Recall Participant Percentage

    Time frame: 30 days

    Number/percentage of participants able to recall 2 or more symptoms of the FAST mnemonic or 3 or more of the BE-FAST mnemonic.

  5. Common Recall Participant Percentage

    Time frame: 30 days

    Number/percentage of participants able to recall the more common symptoms of each mnemonic (Facial weakness, arm weakness and speech difficulties)

  6. Retention per Professional Background

    Time frame: 30 days

    Compare participants with medical vs. non-medical professional backgrounds and explore whether there are any group differences in retention rates.

Sponsors and collaborators

Lead sponsor

Wake Forest University Health Sciences

Other

Collaborators

  • Aurora BayCare Medical Center
  • BayCare Health System

Registry information

Official study title

BE FAST vs. FAST: A Randomized Trial Comparing Retention of Stroke Symptoms Between Two Mnemonics in the General Public.

Acronym: BFF

Important dates

Study start
2021
Primary completion
2023
Study completion
2023
First posted
Nov 30, 2023
Registry last updated
Oct 3, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.